节点文献

三七皂苷抗肝纤维化作用的现状

Effectiveness of saponins from Panax notoginseng against hepatic fibrosis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张娴文李凤贤李辉

【Author】 ZHANG Xian-wen1,LI Feng-xian2,LI Hui1(1 Department of Pharmacology,2 Department of Internal Medicine,Dali College,Dali 671000,China)

【机构】 云南省大理学院药理教研室云南省大理学院内科教研室云南省大理学院药理教研室 大理671000大理671000

【摘要】 肝纤维化是各种慢性肝病共同的病理基础,是慢性肝病发展到肝硬化、肝癌的必经途径。寻找有效的抗肝纤维化药物是近年研究的热点,其中对三七的研究也取得了很大进展。现综述近几年三七皂苷在保护肝细胞、抑制肝星状细胞活化、促进肝星状细胞凋亡、抑制细胞外基质的合成及促使其降解等方面的作用及可能机制,同时也阐述了三七皂苷在抗肝纤维化中的重要意义及应用前景。

【Abstract】 Hepatic fibrosis is an essential pathological process involved in various chronic hepatic diseases that may deteriorate into hepatic cirrhosis and hepatic cancer.Thus,it has become hot topics to seek bioactive components against hepatic fibrosis.Many researches found that saponins from Panax notoginseng have the potential to be a bioactive agent against hepatic fibrosis.This review summarizes the research findings that saponins from Panax notoginseng showed a protection of hepatic cells from the fibrosis by inhibition of hepatic stellate cells and synthesis of extracellular matrix,promoting apoptosis of hepatic stellate cells and degradation of extracellular matrix.The prospects of saponins from Panax notoginseng in management of hepatic fibrosis are also elaborated.

  • 【文献出处】 中国新药杂志 ,Chinese Journal of New Drugs , 编辑部邮箱 ,2007年04期
  • 【分类号】R259
  • 【被引频次】13
  • 【下载频次】373
节点文献中: 

本文链接的文献网络图示:

本文的引文网络